News

Search for Articles

Jan 17, 2024

Comanche Biopharma Closes Oversubscribed $75 Million Series B Financing to Advance Mission to Develop and Make Globally Available the First Treatment Targeting a Root Cause of Preeclampsia

Read More

Dec 13, 2023

Acesion Pharma announces Nature Medicine publication of clinical results in Atrial Fibrillation

Read More

Sep 26, 2023

Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation

Read More

Sep 26, 2023

Cardiosense Begins Enrollment in Nationwide Heart Failure Study

Read More

Aug 8, 2023

Nyra Medical names Lori Chmura as Chief Executive Officer

Read More

Jun 20, 2023

HAYA Therapeutics Adds Douglas L. Mann, M.D. as Chairperson of Clinical Advisory Board

Read More